Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longitudinal MRI study of methylphenidate effects in children with ADHD
2007-007552-33Phase 4Active
- Sponsor
- CHU Amiens-Picardie
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 cohorts), sponsored by CHU Amiens-Picardie. Primary endpoints: Primary endpoint 1 and Primary endpoint 2. Started Jan 2008; status: active.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2007-007552-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007552-33.